ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Merus NV

Merus NV (2GH)

42.00
0.60
(1.45%)
Closed 11 December 8:00AM
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
42.00
Bid
40.20
Offer
41.40
Volume
557
41.40 Day's Range 42.20
21.40 52 Week Range 58.50
Previous Close
41.40
Open
41.80
Last Trade
5
@
42
Last Trade Time
Average Volume (3m)
150
Financial Volume
-
VWAP
-

2GH Latest News

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC

Zwischenergebnisse der Monotherapie mit Petosemtamab von Merus zeigen weiterhin klinisch signifikante Aktivität bei 2L+ r/m HNSCC Studie mit Petosemtamab in Kombination mit Pembrolizumab bei 1L...

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m

Les données intermédiaires de Merus portant sur le pétosemtamab continuent de démontrer une activité cliniquement significative dans le traitement de 2e ligne et lignes ultérieures du CETC r/m...

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC

Merus’ Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically Meaningful Activity in 2L+ r/m HNSCC Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing...

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en fonction des données de sécurité et d’efficaci

Merus annonce l’autorisation par la FDA de BIZENGRI® (zénocutuzumab-zbco) dans le traitement de l’adénocarcinome pancréatique NRG1+ et du cancer du poumon non à petites cellules (CPNPC) NRG1+, en...

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und Wirksamkeitsdaten aus der eNRGy-Studie bekannt

Merus gibt FDA-Zulassung von BIZENGRI® (Zenocutuzumab-zbco) für NRG1+-Adenokarzinome der Bauchspeicheldrüse und NRG1+-nicht-kleinzelligen Lungenkrebs (NSCLC) auf der Grundlage von Sicherheits- und...

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-3.6-7.8947368421145.645.639.650741.91558185DE
4-6.2-12.863070539448.248.239.617842.85404101DE
12-3.2-7.079646017745.251.539.615046.14471602DE
26-7-14.28571428574957.539.616948.03577184DE
522090.90909090912258.521.39999917944.24911102DE
15618.276.470588235323.858.51917141.97393714DE
26018.276.470588235323.858.51917141.97393714DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CXFChimerix Inc
2.645 €
(224.94%)
354.38k
UQ1Uniqure NV
14.565 €
(110.66%)
49.65k
XE7CCardiff Oncology Inc
3.645 €
(57.79%)
147.73k
9DRGlimpse Group
1.20 €
(52.87%)
14.47k
KH6NewAmsterdam Pharma Company NV
25.00 €
(42.05%)
1.23k
TE9Teco 2030 ASA
0.0142 €
(-75.00%)
1.38M
0PV2Moovly Media Inc
0.0025 €
(-58.33%)
560
KEHChinese People Holdings Co Ltd
0.0015 €
(-50.00%)
42.7k
PA8Paion AG
0.0132 €
(-45.90%)
844
1R6Alset AI Ventures Inc
0.048 €
(-31.91%)
101.8k
AXIAtos SE
0.0023 €
(-14.81%)
741.04M
D7GNel ASA
0.2702 €
(0.11%)
4.2M
PF8European Lithium Limited
0.026 €
(-2.99%)
2.1M
3CPXiaomi Corporation
3.8005 €
(-2.43%)
2.05M
TE9Teco 2030 ASA
0.0142 €
(-75.00%)
1.38M

Discussion

View Full Feed
EnchantedTitan62 EnchantedTitan62 3 minutes ago
But you can let people pump XTIA that sells for less than a nickel! Trust me, I'll stay away from your board.
XTIA
badgerkid badgerkid 3 minutes ago
Sunman, "What (are) the major drivers to get SP higher? What are the major barriers to prevent this from happening?"

I'd like to hear your answers.

As a "cheerleader", I'm still able to see the score of the game and understand that some things will not play out as pre
IOVA
1vman 1vman 4 minutes ago
***** 🚽HCMC🚽 84.9 - Million XPERT Sells as volume continues to be anemic

https://ih.advfn.com/stock-market/USOTC/healthier-choices-manage-pk-HCMC/trades?_gl=1*d6gmns*_gcl_au*MzUyNzIzMTIxLjE3MjgzOTMxMjM.

ENOUGH SAID HUZZAH🤪 !!!
HCMC
mrfence mrfence 4 minutes ago
OMG! On page 601, Agenda 25 stands up for the rights of workers to organize 🫨

Injunctive Relief and Worker Organizing Activities. Within the confines
of the more reasonable definition of protected concerted activity described above,
the NLRB should increase its
FNMA
1vman 1vman 5 minutes ago
***** 🚽MJNA🚽 Short high !!! cover low !!! .0001

PEE YEW !!! Stinky OTC pinky here

Rinse and repeat

ENOUGH SAID HUZZAH 🤪!!!
MJNA
Legend431 Legend431 5 minutes ago
Hey Dud

I did my own chatGPT (since you always use it) and I asked if NWBO could have paid pumpers and here is what it said and you and multiple others like crash fall on the category of #2 unusally positive or overhyped claims. I also posted a link to Hoffscam's misleading tweet tell
NWBO
8lang 8lang 5 minutes ago
There have a Agreement the pfds "P" will changing to LEH new common share .......
LEHNQ
KenKong KenKong 5 minutes ago
Except that Russell Vought is going to be head of OMB. Office of Management and Budget. The most powerful unknown agency. 

Who's he? Co-author of Project 2025. 
style="caret-color: rgb(24, 28, 54); color: rgba(24, 28, 54, 1); font-family: Soehne, "Helvetica Neue", helvetica, a
FNMA
BullNBear52 BullNBear52 5 minutes ago
What's odd is he gave the cop the fake ID he used at the Hostel instead of his real ID. And since it was a ghost gun he really should have ditched it.
Mr. C Mr. C 6 minutes ago
It’s not current money. It’s based on future investment. If your project is over a billion dollars then you get expedited approvals
TGLO
getmoreshares getmoreshares 6 minutes ago
get your sign yet??? No-not flipping
CGAC
haha11 haha11 7 minutes ago
$UPRO.........$UPRO ..30.... 60.....+....DLY.....Trend LL . today... 12/10/2024 ...E.O.D....COMMENT

UPRO BULL .. .FLIP .From BULL TO BEAR..STATUS.. .OPINION .

UPRO 30.
https://schrts.co/zIyhsvWI
60....
https://schrts.co/CvcHwFaP
DL
UPRO
PAUL_MARKOWITZ PAUL_MARKOWITZ 7 minutes ago
Get those PUTS early tomorrow....you gotta see opportunities for puts when these stocks run so much.

Got in 60 puts $400 12/13 at $3.05, sold them $7.31 an hour and a half or so afterwards...banked just over 25,500 easily.

I want these swings tomorrow....😊
TSLA
Renee Renee 7 minutes ago
SEHCF: a one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
SEHCF
m0n m0n 7 minutes ago
Did ya like the latest update stating England as a POD?

i guess its ok to say the product line was sold in England back in 2013-2014 LoL

No One is Fooled 
IFUS
crazy horse 0 crazy horse 0 7 minutes ago
ON the Shooter Luigi Mangione

https://scontent-mia3-1.xx.fbcdn.net/v/t39.30808-6/469871566_10232626453616725_745480835682802334_n.jpg?_nc_cat=106&ccb=1-7&_nc_sid=aa7b47&_nc_ohc=SaQAFFKtSRYQ7kNvgHI6U55&_nc_zt=23&_nc_ht=scontent-mia3-1.xx&_nc_gid=AnPtCRZ3sXWu84WSzTcl6Rj&oh=00_AYAAv5sRzi
ohsaycanyousee82 ohsaycanyousee82 7 minutes ago
Just like the Biden Administration.
AVXL
JJ8 JJ8 8 minutes ago
Wow, what a steep rise in share price! Congrats if you have the shares.

No wonder chart shows pattern of "Long Tail Up since 5-Dec-2024" at this time. Suggesting a likely price correction.

Cheers & GLTY
NVDA
Drugdoctor Drugdoctor 9 minutes ago
Yea, sigh, it could sink back to mid 2s also, as the pumper dumpers that were attracted to the breakout and volume give up and slink away, lol. If so, some of us will be adding hard I bet.
GVSI
Dingbatt Dingbatt 9 minutes ago
Flippity Flop could rise to the top.
RNVA
m0n m0n 9 minutes ago
HuH? it's in the .04 range ya dope! LoL

Ya just can't fix stupid


IFUS
Orange Cassidy Orange Cassidy 9 minutes ago
Stop the cap you have been here since 2021 what about the other shares this stock was nowhere near those prices until 2023
?
I couldn’t be any happier with my original triple ones and twos!!!
NBRI
EnchantedTitan62 EnchantedTitan62 10 minutes ago
Thanks for letting me know. 👍

Your Recent History

Delayed Upgrade Clock